Chromosomal inversions as a hidden disease-modifying factor for somatic recombination phenotypes

Area of Science:

• Human Genetics
• Genomics
• Molecular Biology

Background:

• Heterozygous chromosomal inversions are known to suppress genetic recombination.
• Their potential influence on recombination-associated human disease phenotypes remains unverified.
• Congenital ichthyosis is a group of skin disorders, with some types linked to recombination-induced reversion of mutations.

Observation:

• A patient with severe congenital ichthyosis presented with a KRT10 gene mutation, typically associated with ichthyosis with confetti (IWC-I).
• This patient exhibited fewer revertant skin areas than typical IWC-I cases.
• G-banded karyotyping revealed a heterozygous inversion, inv(17)(p13q12), in the patient.

Findings:

• The KRT10 mutation and the inversion breakpoint on chromosome 17 were implicated in revertant mosaicism.
• Somatic recombination between the KRT10 mutation and the inversion breakpoint was observed to diminish the mutation in revertant skin spots.
• The patient's reduced revertant spots correlated with recombination suppression due to the inversion.

Implications:

• This study provides the first evidence that chromosomal inversions can modify clinical disease phenotypes.
• The findings suggest somatic recombination is the primary mechanism for revertant mosaicism in IWC-I.
• Understanding inversion effects on recombination is crucial for studying genetic disease mechanisms and variability.